Mitochondrial Epigenetic Changes Link to Increased Diabetes Risk and Early-Stage Prediabetes Indicator

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Zheng, Louise D ^a   Linarelli, Leah E ^a   Brooke, Joseph ^a   Smith, Cayleen ^a   Wall, Sarah S ^a   Greenawald, Mark H ^b   Seidel, Richard W ^b   Estabrooks, Paul A ^a,b,c   Almeida, Fabio A ^a,c   Cheng, Zhiyong ^a  

^a Fralin Translational Obesity Research Center   (United States)

^b CARILION CLINIC   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; BIOMARKERS; DNA; INSULIN; METHYLATION;

BODY MASS INDEX; DISEASE PREVENTION; EARLY DIAGNOSIS; INSULIN SENSITIVITY; LATE STAGE; MITOCHONDRIAL DNA; TYPE-2 DIABETES;

DIAGNOSIS;

BIOLOGICAL MARKER; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LOW DENSITY LIPOPROTEIN; MITOCHONDRIAL DNA; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA METHYLATION; DNA REPLICATION; EARLY DIAGNOSIS; ENDOCRINE FUNCTION TEST; EPIGENETICS; FASTING PLASMA GLUCOSE LEVEL; FEMALE; GENETIC MARKER; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL GENETICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ADULT; BLOOD; DEMOGRAPHY; DIABETES MELLITUS; DIET RESTRICTION; GENETIC EPIGENESIS; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; MITOCHONDRION; OBESITY; PREDIABETIC STATE;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DEMOGRAPHY; DIABETES MELLITUS; DNA METHYLATION; DNA, MITOCHONDRIAL; EPIGENESIS, GENETIC; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; MALE; MITOCHONDRIA; OBESITY; PREDIABETIC STATE; RISK FACTORS;

EID: 84973338459     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/5290638     Document Type: Article

References (53)

1. J. Tuomilehto, J. Lindstrm, J. G. Eriksson et al., "Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance," The New England Journal of Medicine, vol. 344, no. 18, pp. 1343-1350, 2001.
2. E. S. Schellenberg, D. M. Dryden, B. Vandermeer, C. Ha, C. Korownyk, "Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis," Annals of Internal Medicine, vol. 159, no. 8, pp. 543-551, 2013.
3. P. Tuso, "Prediabetes and lifestyle modification: time to prevent a preventable disease,"ThePermanente Journal, vol. 18,no. 3, pp. 88-93, 2014.
4. T. Temelkova-Kurktschiev and T. Stefanov, "Lifestyle and genetics in obesity and type 2 diabetes," Experimental and Clinical Endocrinology and Diabetes, vol. 120, no. 1, pp. 1-6, 2012.
5. Z. Cheng and F. A. Almeida, "Mitochondrial alteration in type 2 diabetes and obesity: an epigenetic link," Cell Cycle, vol. 13, no. 6, pp. 890-897, 2014.
6. Z. Cheng, E. M. Schmelz, D. Liu,M. W. Hulver, "Targeting mitochondrial alterations to prevent type 2 diabetes-evidence from studies of dietary redox-active compounds," Molecular Nutrition and Food Research, vol. 58, no. 8, pp. 1739-1749, 2014.
7. R. Rab, R. Boushel, F. Dela, "Mitochondrial oxidative function and type 2 diabetes," Applied Physiology, Nutrition and Metabolism, vol. 31, no. 6, pp. 675-683, 2006.
8. M.-E. Patti and S. Corvera, "The role of mitochondria in the pathogenesis of type 2 diabetes," Endocrine Reviews, vol. 31, no. 3, pp. 364-395, 2010.
9. J. B. Buse, S. Caprio, W. T. Cefalu et al., "How do we define cure of diabetes" Diabetes Care, vol. 32, no. 11, pp. 2133-2135, 2009.
10. C. D. Saudek, "Can diabetes be cured Potential biological and mechanical approaches," The Journal of the American Medical Association, vol. 301, no. 15, pp. 1588-1590, 2009.
11. K. M. V. Narayan, J. P. Boyle, T. J. Thompson, E. W. Gregg, D. F. Williamson, "Effect of BMI on lifetime risk for diabetes in the US," Diabetes Care, vol. 30, no. 6, pp. 1562-1566, 2007.
12. American Diabetes Association, "Classification and diagnosis of diabetes," Diabetes Care, vol. 38, supplement, pp. S8-S16, 2015.
13. N. R. Pinelli, A. S. Jantz, E. T. Martin,L. A. Jaber, "Sensitivity and specificity of glycated hemoglobin as a diagnostic test for diabetes and prediabetes in Arabs," Journal of Clinical Endocrinology andMetabolism, vol. 96,no. 10, pp. E1680-E1683, 2011.
14. I. B. Hirsch andM. Brownlee, "Beyond hemoglobin A1c-need for additional markers of risk for diabetic microvascular complications," The Journal of theAmericanMedical Association, vol. 303, no. 22, pp. 2291-2292, 2010.
15. R. M. Cohen and C. J. Lindsell, "When the blood glucose and the HbA1c don't match: turning uncertainty into opportunity," Diabetes Care, vol. 35, no. 12, pp. 2421-2423, 2012.
16. A. E. Kitabchi, M. Temprosa, W. C. Knowler et al., "Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program effects of lifestyle intervention andmetformin," Diabetes, vol. 54, no. 8, pp. 2404-2414, 2005.
17. C. Ling and T. Rnn, "Epigenetic adaptation to regular exercise in humans," Drug Discovery Today, vol. 19, no. 7, pp. 1015-1018, 2014.
18. L. D. Zheng, L. E. Linarelli, L. Liu et al., "Insulin resistance is associated with epigenetic and genetic regulation of mitochondrial DNA in obese humans," Clinical Epigenetics, vol. 7, article 60, 2015.
19. E. V. Menshikova, V. B. Ritov, L. Fairfull, R. E. Ferrell, D. E. Kelley, B. H. Goodpaster, "Effects of exercise on mitochondrial content and function in aging human skeletal muscle," Journals of Gerontology-Series A: Biological Sciences and Medical Sciences, vol. 61, no. 6, pp. 534-540, 2006.
20. N. T. Broskey, A. Boss, E. Fares et al., "Exercise efficiency relates with mitochondrial content and function in older adults," Physiological Reports, vol. 3, no. 6, Article ID e12418, 2015.
21. N. T. Broskey, C. Greggio, A. Boss et al., "Skeletal muscle mitochondria in the elderly: effects of physical fitness and exercise training," Journal of Clinical Endocrinology andMetabolism, vol. 99, no. 7, pp. 1852-1861, 2014.
22. B. A. Irving, I. R. Lanza, G. C. Henderson, R. R. Rao, B. M. Spiegelman, K. Sreekumaran Nair, "Combined training enhances skeletal muscle mitochondrial oxidative capacity independent of age," Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 4, pp. 1654-1663, 2015.
23. A. W. Gao, C. Cant, R. H. Houtkooper, "Mitochondrial response to nutrient availability and its role in metabolic disease," EMBO Molecular Medicine, vol. 6, no. 5, pp. 580-589, 2014.
24. A. G. Tabk, C. Herder, W. Rathmann, E. J. Brunner, M. Kivimki, "Prediabetes: a high-risk state for diabetes development," The Lancet, vol. 379, no. 9833, pp. 2279-2290, 2012.
25. A. G. Tabk, M. Jokela, T. N. Akbaraly, E. J. Brunner, M. Kivimki, D. R. Witte, "Trajectories of glycaemia, insulin sensitivity, insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study," The Lancet, vol. 373, no. 9682, pp. 2215-2221, 2009.
26. Y. Heianza, Y. Arase, K. Fujihara et al., "Longitudinal trajectories of HbA1c and fasting plasma glucose levels during the development of type 2 diabetes: the ToranomonHospitalHealth Management Center Study 7 (TOPICS 7)," Diabetes Care, vol. 35, no. 5, pp. 1050-1052, 2012.
27. F. A. Almeida, K. A. Pardo, R. W. Seidel et al., "Design and methods of 'diaBEAT-it!': a hybrid preference/randomized control trial design using the RE-AIM framework," Contemporary Clinical Trials, vol. 38, no. 2, pp. 383-396, 2014.
28. F. X. Xu, X. Zhou, F. Shen, R. Pang, S. M. Liu, "Decreased peripheral blood mitochondrial DNA content is related to HbA1c, fasting plasma glucose level and age of onset in type 2 diabetes mellitus," DiabeticMedicine, vol. 29, no. 7, pp. e47-e54, 2012.
29. T. M. Wallace, J. C. Levy, D. R. Matthews, "Use and abuse of HOMA modeling," Diabetes Care, vol. 27, no. 6, pp. 1487-1495, 2004.
30. F. F. Zhang, R. M. Santella, M. Wolff, M. A. Kappil, S. B. Markowitz, A. Morabia, "White blood cell global methylation and IL-6 promotermethylation in associationwith diet and lifestyle risk factors in a cancer-free population," Epigenetics, vol. 7, no. 6, pp. 606-614, 2012.
31. K. B. Michels, H. R. Harris, L. Barault, "Birthweight, maternal weight trajectories and global DNA methylation of LINE-1 repetitive elements," PLoS ONE, vol. 6, no. 9,Article ID e25254, 2011.
32. C. J. Pirola, T. F. Gianotti, A. L. Burgueño et al., "Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease," Gut, vol. 62, no. 9, pp. 1356-1363, 2013.
33. S. Sookoian, M. S. Rosselli, C. Gemma et al., "Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferatoractivated receptor coactivator 1 promoter," Hepatology, vol. 52, no. 6, pp. 1992-2000, 2010.
34. L.-C. Li and R. Dahiya, "MethPrimer: designing primers for methylation PCRs," Bioinformatics, vol. 18, no. 11, pp. 1427-1431, 2002.
35. American Diabetes Association, "Consensus development conference on insulin resistance: 5-6 November 1997," Diabetes Care, vol. 21, no. 2, pp. 310-314, 1998.
36. V. Pisprasert, K. H. Ingram, M. F. Lopez-Davila, A. J. Munoz, W. T. Garvey, "Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in AfricanAmericans," Diabetes Care, vol. 36, no. 4, pp. 845-853, 2013.
37. M. L. Ganz, N. Wintfeld, Q. Li, V. Alas, J. Langer, M. Hammer, "The association of body mass index with the risk of type 2 diabetes: a case-control study nested in an electronic health records system in the United States," Diabetology & Metabolic Syndrome, vol. 6, article 50, 2014.
38. A. Schienkiewitz, M. B. Schulze, K. Hoffmann, A. Kroke, H. Boeing, "Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study," American Journal of Clinical Nutrition, vol. 84, no. 2, pp. 427-433, 2006.
39. E. W. Gregg, H. Chen, L. E. Wagenknecht et al., "Association of an intensive lifestyle intervention with remission of type 2 diabetes,"The Journal of the AmericanMedical Association, vol. 308, no. 23, pp. 2489-2496, 2012.
40. C. M. Ulrich, A. T. Toriola, L. M. Koepl et al., "Metabolic, hormonal and immunological associations with global DNA methylation among postmenopausal women," Epigenetics, vol. 7, no. 9, pp. 1020-1028, 2012.
41. V. Turcot, A. Tchernof, Y. Deshaies et al., "LINE-1 methylation in visceral adipose tissue of severely obese individuals is associated with metabolic syndrome status and related phenotypes," Clinical Epigenetics, vol. 4, no. 1, article 10, 2012.
42. M. S. Pearce, J. C. McConnell, C. Potter et al., "Global LINE-1 DNA methylation is associated with blood glycaemic and lipid profiles," International Journal of Epidemiology, vol. 41, no. 1, pp. 210-217, 2012.
43. C. Duggan, L. Xiao, M. B. Terry, A. McTiernan, "No effect of weight loss on LINE-1 methylation levels in peripheral blood leukocytes from postmenopausal overweight women," Obesity, vol. 22, no. 9, pp. 2091-2096, 2014.
44. G. M. Mart-Nñez, R. Cabrera-Mulero, E. Rubio-Mart et al., "Methylation levels of the SCD1 gene promoter and LINE-1 repeat region are associatedwithweight change: an intervention study,"Molecular Nutrition and Food Research, vol. 58, no. 7, pp. 1528-1536, 2014.
45. L. Delgado-Cruzata, W. Zhang, J. A. McDonald et al., "Dietary modifications, weight loss, changes in metabolic markers affect global DNA methylation in Hispanic, African American, Afro-Caribbean breast cancer survivors," Journal of Nutrition, vol. 145, no. 4, pp. 783-790, 2015.
46. T. Rnn, P. Volkov, C. Davegardh et al., "A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue," PLoS Genetics, vol. 9, no. 6, Article ID e1003572, 2013.
47. M. D. Nitert, T. Dayeh, P. Volkov et al., "Impact of an exercise intervention on DNAmethylation in skeletalmuscle fromfirstdegree relatives of patients with type 2 diabetes," Diabetes, vol. 61, no. 12, pp. 3322-3332, 2012.
48. Z. Cheng and M. Ristow, "Mitochondria and metabolic homeostasis," Antioxidants & Redox Signaling, vol. 19, no. 3, pp. 240-242, 2013.
49. J. Nunnari and A. Suomalainen, "Mitochondria: in sickness and in health," Cell, vol. 148, no. 6, pp. 1145-1159, 2012.
50. Z. Cheng, Y. Tseng, M. F. White, "Insulin signaling meets mitochondria in metabolism," Trends in Endocrinology and Metabolism, vol. 21, no. 10, pp. 589-598, 2010.
51. Z. Cheng, S. Guo, K. Copps et al., "Foxo1 integrates insulin signaling with mitochondrial function in the liver," Nature Medicine, vol. 15, no. 11, pp. 1307-1311, 2009.
52. A. Sleigh, P. Raymond-Barker, K. Thackray et al., "Mitochondrial dysfunction in patients with primary congenital insulin resistance," Journal of Clinical Investigation, vol. 121, no. 6, pp. 2457-2461, 2011.
53. AMA and CDC, New AMA, CDC Initiative Aims to "Prevent Diabetes STAT", 2015, http://www. cdc. gov/media/releases/2015/p0311-diabetes-stat. html.